A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

NCT06579755 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
800
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda